foto
LATEST NEWS

 OctoPlus announces 2010 first half-year results



WEBCAST HALF-YEAR RESULTS

Click here to access the webcast of 6 August 2010



OCTOPLUS OPENED NYSE EURONEXT

In celebration of OctoPlus' 15 year anniversday, CEO Simon Sturge and CFO Susan Swarte opened the financial markets in Amsterdam on Tuesday 27 July



OCTOPLUS ANNUAL REPORT 2009
VIEW OUR WEB SEMINARS
OCTO SHARE PRICE
HOME dashNL dash CONTACT

 

WEB SEMINAR ON LIPOSOMES

Web seminar on liposomes for drug delivery
This web seminar took place on 4 June 2009. 
You can view the webcast of this seminar here (QuickTime required).

Liposomes for drug delivery: what, why and how?

Why you should participate:
- Gain insight into the benefits of liposome drug delivery and the technical challenges of liposome formulation and production
- Hear about the experience in this area from speakers from Utrecht University and OctoPlus
- Join an interactive webinar that leaves ample opportunity to discuss your experience or questions regarding liposomal drug delivery

Speakers include:
Prof. Daan Crommelin, Utrecht University
Professor Crommelin is professor at the Department of Pharmaceutics at Utrecht University. He is adjunct professor at the Department of Pharmaceutics and Pharmaceutical Chemistry at the University of Utah. Prof. Crommelin published extensively and is on the editorial board of 10 peer reviewed journals in the pharmaceutical sciences.

What you can learn:
Liposomes are versatile carriers of a wide array of active molecules. By tailoring their pharmacokinetics, reducing toxicity, targeting to specific organs or lesions, liposomes can accommodate virtually any drug delivery strategy.

Selection of lipids, a suitable processing method, up-scaling of liposomal formulations and manufacture at a commercial scale must be dealt with before liposomal formulations can become a viable product. The scaling up of a bench scale preparation method to an industrial production process is a challenging task, but can be done successfully when specific expertise and appropriate equipment are available. These aspects will be discussed during the webinar and there will be ample opportunity to discuss your experience or questions regarding liposome formulations.